Botulinum Toxin in Raynaud's Phenomenon

Summary

Raynaud's Phenomenon (RP) is the most common vasospastic disorder encountered by hand surgeons with an estimated prevalence of 5% in the general population. It's manifestations are broad, and can range from minor to severe. Sometimes it can be refractory to treatments. The goal of this study is to evaluate the efficacy of Botulinum toxin (BT) in the treatment of treatment refractory RP by objective and subjective measures.

Timeline

Start

2022-02-10

Primary completion

2025-12

Completion

2025-12

Drugs

Indications